Literature DB >> 26266872

New Insights into the Roles of Nogo-A in CNS Biology and Diseases.

Yun-Peng Sui1, Xiao-Xi Zhang, Jun-Lin Lu, Feng Sui.   

Abstract

Nogos have become a hot topic for its well-known number Nogo-A's big role in clinical matters. It has been recognized that the expression of Nogo-A and the receptor NgR1 inhibit the neuron's growth after CNS injuries or the onset of the MS. The piling evidence supports the notion that the Nogo-A is also involved in the synaptic plasticity, which was shown to negatively regulate the strength of synaptic transmission. The occurrence of significant schizophrenia-like behavioral phenotypes in Nogo-A KO rats also added strong proof to this conclusion. This review mainly focuses on the structure of Nogo-A and its corresponding receptor-NgR1, its intra- and extra-cellular signaling, together with its major physiological functions such as regulation of migration and distribution and its related diseases like stroke, AD, ALS and so on.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26266872     DOI: 10.1007/s11064-015-1671-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  152 in total

Review 1.  Functions of Nogo proteins and their receptors in the nervous system.

Authors:  Martin E Schwab
Journal:  Nat Rev Neurosci       Date:  2010-11-03       Impact factor: 34.870

2.  Protein folding at the membrane interface, the structure of Nogo-66 requires interactions with a phosphocholine surface.

Authors:  Sheeja V Vasudevan; Jessica Schulz; Chunyi Zhou; Melanie J Cocco
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

3.  Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact.

Authors:  Xingxing Wang; Soo-Jin Chun; Helen Treloar; Timothy Vartanian; Charles A Greer; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

4.  Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength.

Authors:  Hakjoo Lee; Stephen J Raiker; Karthik Venkatesh; Rebecca Geary; Laurie A Robak; Yu Zhang; Hermes H Yeh; Peter Shrager; Roman J Giger
Journal:  J Neurosci       Date:  2008-03-12       Impact factor: 6.167

5.  The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination.

Authors:  Tara Karnezis; Wim Mandemakers; Jonathan L McQualter; Binhai Zheng; Peggy P Ho; Kelly A Jordan; Belinda M Murray; Ben Barres; Marc Tessier-Lavigne; Claude C A Bernard
Journal:  Nat Neurosci       Date:  2004-06-06       Impact factor: 24.884

6.  The membrane topology of RTN3 and its effect on binding of RTN3 to BACE1.

Authors:  Wanxia He; Qi Shi; Xiangyou Hu; Riqiang Yan
Journal:  J Biol Chem       Date:  2007-08-15       Impact factor: 5.157

7.  Cell type-specific Nogo-A gene ablation promotes axonal regeneration in the injured adult optic nerve.

Authors:  F Vajda; N Jordi; D Dalkara; S Joly; F Christ; B Tews; M E Schwab; V Pernet
Journal:  Cell Death Differ       Date:  2014-09-26       Impact factor: 15.828

8.  Myelin-associated glycoprotein and myelin galactolipids stabilize developing axo-glial interactions.

Authors:  Jill Marcus; Jeffrey L Dupree; Brian Popko
Journal:  J Cell Biol       Date:  2002-02-04       Impact factor: 10.539

9.  Enhanced neurite outgrowth of human model (NT2) neurons by small-molecule inhibitors of Rho/ROCK signaling.

Authors:  Frank Roloff; Hannah Scheiblich; Carola Dewitz; Silke Dempewolf; Michael Stern; Gerd Bicker
Journal:  PLoS One       Date:  2015-02-25       Impact factor: 3.240

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  7 in total

Review 1.  Monoclonal antibody as an emerging therapy for acute ischemic stroke.

Authors:  Demi Woods; Qian Jiang; Xiang-Ping Chu
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-08-25

2.  Conditional Overexpression of rtn4al in Muscle of Adult Zebrafish Displays Defects Similar to Human Amyotrophic Lateral Sclerosis.

Authors:  Cheng-Yung Lin; Po-Hsiang Zhang; You-Jei Chen; Chia-Lun Wu; Huai-Jen Tsai
Journal:  Mar Biotechnol (NY)       Date:  2018-11-15       Impact factor: 3.619

3.  Metformin-induced AMPK activation stimulates remyelination through induction of neurotrophic factors, downregulation of NogoA and recruitment of Olig2+ precursor cells in the cuprizone murine model of multiple sclerosis.

Authors:  Fariba Houshmand; Mahmood Barati; Fereshteh Golab; Samaneh Ramezani-Sefidar; Sara Tanbakooie; Mahsa Tabatabaei; Masoomeh Amiri; Nima Sanadgol
Journal:  Daru       Date:  2019-10-16       Impact factor: 3.117

4.  Decreased Expression of α-Synuclein, Nogo-A and UCH-L1 in Patients with Schizophrenia: A Preliminary Serum Study.

Authors:  Ömer Faruk Demirel; İhsan Cetin; Şenol Turan; Tarık Sağlam; Nazım Yıldız; Alaattin Duran
Journal:  Psychiatry Investig       Date:  2017-05-16       Impact factor: 2.505

5.  A Nogo-Like Signaling Perspective from Birth to Adulthood and in Old Age: Brain Expression Patterns of Ligands, Receptors and Modulators.

Authors:  Gabriella Smedfors; Lars Olson; Tobias E Karlsson
Journal:  Front Mol Neurosci       Date:  2018-02-19       Impact factor: 5.639

6.  CircRTN4 promotes pancreatic cancer progression through a novel CircRNA-miRNA-lncRNA pathway and stabilizing epithelial-mesenchymal transition protein.

Authors:  Chi Hin Wong; Ut Kei Lou; Frederic Khe-Cheong Fung; Joanna H M Tong; Chang-Hua Zhang; Ka-Fai To; Stephen Lam Chan; Yangchao Chen
Journal:  Mol Cancer       Date:  2022-01-04       Impact factor: 27.401

7.  Early constraint-induced movement therapy affects behavior and neuronal plasticity in ischemia-injured rat brains.

Authors:  Xi-Hua Liu; Hong-Yan Bi; Jie Cao; Shuo Ren; Shou-Wei Yue
Journal:  Neural Regen Res       Date:  2019-05       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.